Delivery Order SPE2DR25D3101-SPE2DR26F5S53
- Not listed
- The Defense Logistics Agency awarded a $25,456.08 delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections on November 12, 2025, with completion targeted for November 13, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, consistent with AmerisourceBergen's...
- The Defense Logistics Agency awarded a $8,276.01 delivery order to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 ml pen injections on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control in patients with type 2 diabetes. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,804.27 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injections on May 16, 2025, with an ultimate completion date of May 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $2,412.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pen injections on November 14, 2025, with completion targeted for November 17, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,468.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections on August 12, 2025, with an ultimate completion date of August 13, 2025. This is an unset-aside, competitively awarded contract with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $5,060.48 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injections with a completion deadline of December 2, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX,...
- The Defense Logistics Agency awarded a $3,265.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injections. The contract, with an ultimate completion date of November 3, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen's Conshohocken, Pennsylvania facility serves as the place of performance. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,445.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injections. This is a non-set-aside competitive award with an ultimate completion date of December 10, 2025, and represents a single delivery order fulfillment from AmerisourceBergen's existing federal contract portfolio. The product will be delivered to the company's corporate headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $10,883.60 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on September 24, 2025, with completion targeted for September 25, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $11,240.59 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injections. This contract, awarded on October 30, 2025, with an ultimate completion date of October 31, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- SPE2DR25D3101Indefinite Delivery Contract
- SPE2DR25D3101-SPE2DR26F5S53Delivery Order
The Defense Logistics Agency awarded a $4,123.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections on December 10, 2025, with completion due by December 11, 2025. This non-set-aside competitive award was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control in patients with type 2 diabetes. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a comprehensive range of brand-name and generic medications, vaccines, and medical devices to support military and veteran healthcare systems. This delivery order represents a routine procurement transaction under the larger prime vendor contract structure, enabling the company to fulfill federal medical supply needs across multiple therapeutic domains for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 12/9/25 |